Cancer Research

Can Gene Therapy Transform Hemophilia B Treatment Forever?
Research & Development Can Gene Therapy Transform Hemophilia B Treatment Forever?

Modern medicine continually strives to overcome the limitations of traditional treatments for rare genetic disorders, seeking transformative solutions that can significantly improve patients' lives. Among these conditions, hemophilia B—a genetic disorder inhibiting blood clotting primarily in

Enhancing CAR-T Cells to Combat Solid Tumors with CRISPR
Research & Development Enhancing CAR-T Cells to Combat Solid Tumors with CRISPR

In recent years, the battle against cancer has seen the emergence of innovative approaches, particularly in immunotherapy. Chimeric Antigen Receptor (CAR) T cell therapy, famously effective against blood cancers, faces significant hurdles when applied to solid tumors. A critical challenge is the

EMA Recommends Cabometyx for Advanced Neuroendocrine Tumors
Management & Regulatory EMA Recommends Cabometyx for Advanced Neuroendocrine Tumors

In the realm of medical advancements, addressing the challenge of treating advanced neuroendocrine tumors (NETs) is crucial, given their complex nature and slow progression. These tumors arise from neuroendocrine cells dispersed throughout the body, posing significant treatment demands. A pivotal

Hetronifly Approved by UK to Treat Aggressive Lung Cancer
Management & Regulatory Hetronifly Approved by UK to Treat Aggressive Lung Cancer

The UK has taken a monumental step in the fight against extensive-stage small cell lung cancer (SCLC) with the recent approval of Hetronifly. This approval by the Medicines and Healthcare products Regulatory Agency (MHRA) introduces Hetronifly as the first anti-PD-1 monoclonal antibody available in

Mitochondrial Drugs Revolutionize Melanoma Treatment Strategies
Research & Development Mitochondrial Drugs Revolutionize Melanoma Treatment Strategies

In recent months, pivotal discoveries in melanoma research have unveiled game-changing insights that could reshape the therapeutic landscape for one of the most aggressive skin cancers. Traditionally, treatment options for melanoma have struggled with effectively targeting the disease due to its

EU Panel Backs Darzalex for Early-Stage Multiple Myeloma
Management & Regulatory EU Panel Backs Darzalex for Early-Stage Multiple Myeloma

In the world of oncology, advancements in treatment options often mark pivotal moments in patient care. Ivan Kairatov, a biopharma expert with profound knowledge in tech and innovation, shares insights into the nuanced landscape of smouldering multiple myeloma (SMM) and its treatment. With his

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later